Bremer V, Dudareva-Vizule S, Buder S et al. Sexuell übertragbare Infektionen in Deutschland. Die aktuelle epidemiologische Lage. Bundesgesundheitsbl 2017; 60: 948-957.
Brown ZA, Wald A, Morrow RA et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289(2): 203-209.
Feltner C, Grodensky C, Ebel C et al. Serological Screening for Genital Herpes: An Evidence Review for the U.S. Preventive Services Task Force. (AHRQ Evidence Syntheses; No. 149). 2016.
Heslop R, Roberts H, Flower D, Jordan V. Interventions for men and women with their first episode of genital herpes. Cochrane Database Syst Rev 2016; (8): CD010684.
Hollier LM, Eppes C. Genital herpes: oral anti viral treatments. BMJ Clin Evid 2015: 1603.
Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008; (1): CD004946.
James C, Harfouche M, Welton NJ et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ 2020; 98(5): 315-329.
Korr G, Thamm M, Czogiel I et al. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infect Dis 2017; 17(1): 471.
Kouyoumjian SP, Heijnen M, Chaabna K et al. Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence. AIDS 2018; 32(10): 1343-1352.
Le Cleach L, Trinquart L, Do G et al. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev 2014; (8): CD009036.
Looker KJ, Johnston C, Welton NJ et al. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health 2020; 5(3): e001875.
Looker KJ, Welton NJ, Sabin KM et al. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data. Lancet Infect Dis 2020; 20(2): 240-249.
Obiero J, Ogongo P, Mwethera PG, Wiysonge CS. Topical microbicides for preventing sexually transmitted infections. Cochrane Database Syst Rev 2021; (3): CD007961.
Patel R, Kennedy OJ, Clarke E et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS 2017; 28(14): 1366-1379.
Senat MV, Anselem O, Picone O et al. Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol 2018; 224: 93-101.
Wald A, Langenberg AG, Link K et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285(24): 3100-3106.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.